budenofalk budesonide 3 mg enteric capsules
dr falk pharma australia pty ltd - budesonide, quantity: 3 mg - capsule, enteric - excipient ingredients: sodium lauryl sulfate; purified talc; lactose monohydrate; ammonio methacrylate copolymer; methacrylic acid copolymer; titanium dioxide; erythrosine; iron oxide red; gelatin; iron oxide black; povidone; triethyl citrate; maize starch; sucrose - budenofalk enteric capsules are indicated for: induction of remission in patients with mild to moderately active crohn's disease affecting the ileum and/or the ascending colon (see clinical trials).
carbalex 200mg tablets
g.l. pharma gmbh - carbamazepine - tablets - 200mg
betanor 24mg tablet
noripharma sdn. bhd. - betahistine dihydrochloride -
arina 10mg odt 10 mg
شركة التقدم للصناعات الدوائية - al-taqqadom pharmaceutical industries - aripiprazole 10 mg - 10 mg
arina 15mg odt 15 mg
شركة التقدم للصناعات الدوائية - al-taqqadom pharmaceutical industries - aripiprazole 15 mg - 15 mg
sudafed sinus max strength capsules
mcneil products ltd - caffeine; phenylephrine hydrochloride; paracetamol - oral capsule - 25mg ; 6.1mg ; 500mg
imodium 2 mg capsules
johnson & johnson (ireland) limited - loperamide hydrochloride - capsule, hard - 2 milligram(s) - antipropulsives; loperamide
avelox solution for infusion
bayer pharma ag - moxifloxacin (moxifloxacin hydrochloride) - solution for infusion - 1.6mg/ml
atortonus tablets film-coated
arpimed llc - atorvastatin (atorvastatin calcium trihydrate) - tablets film-coated - 20mg
berlithion 600 ed
berlin-chemie ag - thioctic acid - concentrate for solution for i/v infusion - 25mg/ml